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A B S T R A C T
Physico-chemical investigation of urolithiasis today is mostly focused on applying physico-chemical description of
precipitation processes to the stone formation with the aim to distinguish between stone formers and nonstone formers.
This is done by calculating supersaturation for different solid phases which can be formed in urine using data obtained
by urine analysis and existing solubility product, dissociation and complexation constants. In order for this approach to
succeed it is of utmost importance that system is described as detailed as possible, i.e. that all species that can be formed
are taken into account. Magnesium hydrogenurate octahydrate, Mg(C5H3N4O3)2·8H2O (Mg(HU)2·8H2O), is among spe-
cies which can precipitate in the urine and for which solubility data doesn’t exist. In order to fill this void crystals of
Mg(C5H3N4O3)2·8H2O phase I and phase II have been prepared and characterized. Solubility product constant of
Mg(C5H3N4O3)2·8H2O phase I in water at 37 °C and phase II at different temperatures, pH and in different solvents have
been determined by measuring total concentration of uric acid and magnesium ions in solutions at different time peri-
ods. Results show that in water at 37 °C thermodynamically less stable phase I is more soluble (Ksp=(5.64±0.20)
.10–9 mol3
dm–9) than phase II (Ksp=(1.66±0.13)
.10–9 mol3dm–9). Solubility of Mg(HU)2·8H2O phase II increases with temperature.
At equilibrium the solubility of phase II is the lowest in the presence of excess of magnesium ions, while solubility in the
presence of uric acid is comparable with the one obtained in water.
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Introduction
Urolithiasis, formation of stones in urine, is an impor-
tant medical and social problem. The formation of uri-
nary stones is a complex physico-chemical process, influ-
enced by many factors, the most significant being urine
composition. Urine is frequently oversaturated with re-
spect to different inorganic salts (calcium oxalate, cal-
cium phosphate, sodium and ammonium hydrogenurate)
as well as some organic compounds. Will the stone be
formed in such oversaturated solution depends also on
presence of promoters and inhibitors1.
Parameter which is used for prediction of precipitate
formation in certain system is supersaturation. This ap-
proach has been validated in treatment of urinary stones
formation and reoccurrence, since it enables to deter-
mine if a patient is susceptible to stone formation based
solely on urine composition. Different computer pro-
grams, e.g. EQUIL22 and SEQUIL3, have been used to fa-
cilitate supersaturation calculations in such a complex
solution as urine. However, the success of this calculation
depends on the inclusion of formation and dissociation
constants of all species (precipitates, complexes) which
can be formed. Although much work has been done in de-
termining these parameters for main urinary stone com-
ponents calcium oxalate4,5, calcium phosphate6,7 and uric
acid8,9, data for some urates are scarce10.
Uric acid and its potassium, sodium and calcium salts
urate occur in the acid urine, while ammonium urate can
be found in basic urine. Stones formed at lower pH (<5.5)
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are usually composed of uric acid dyhidrate and anhy-
drous uric acid. Frequency of occurrence of these stones
is around 5%. Uric acid and urates are also found in mix-
ture with calcium oxalates11. Although, chemical compo-
sition and properties of the urates are known, there is
not enough data about their structure and interaction of
the uric acid with some biologically important metals,
such as Mg, Ca, Fe, Co, Cu and Zn.
Magnesium can act as an inhibitor of calcium (calcium
phosphate and oxalate) stone formation12. It can also be
part of the stones in the form of magnesium hydrogenpho-
sphate trihydrate (MgHPO4.3H2O), magnesium ammoni-
umphosphate hexahydrate, struvite (MgNH4PO4.6H2O),
and magnesium phosphate octahydrate Mg3(PO4)2.8H2O13,14
usually in the mixture with calcium oxalates and phos-
phates, urates, cystin and xanthin.
However, although magnesium urate or hydrogen-
urate can be formed in the urine, they were not detected
as urinary stone constituents15. Some authors detected
magnesium – calcium urates in mixture with uric acid as
possible stone constituents10,16.
As early as 1845 Bensch17 has synthesized uric acid
salt of unknown formula, which could be identical to
Mg(C5H3N4O3)2.6H2O, prepared also by Behrend and Ro-
osen18. In 1938 Hannawelt and collaborators19 have pub-
lished d-lines values for magnesium urate MgC5H2N4O3.
Kopajti} and collaborators12,15 have described growth of
the monocrystals of new compound Mg(C5H3N4O3)2.8H2O
two phases. Structures of both phases contain isolated
[Mg(H2O)6]2+ cations, hydrogenurate anions and two mo-
lecules of crystal water per unit cell. Anions are hydro-
gen bonded between themselves and with water mole-
cules, forming chains. Both phases crystallize in mono-
clinic system, phase I in the form of needles and phase II
in the form of plates. Phase II is thermodinamically more
stable12,15. Transformation between two phases occurs in
the solution, but it is long process (2–3 month)20. Data for
magnesium urates physico-chemical characteristics are
scarce or old. For example solubility of Mg(C5H3N4O3)2.
6H2O is 0.043 mmol dm–3 at 22.7 °C as was determined in
184817.
In this paper synthesis and characterization of
Mg(C5H3N4O3)2.8H2O phase I and phase II is described.
Influence of temperature, pH and common ion concen-
tration on solubility of thermodynamically more stable
phase II was also determined.
Materials and Methods
Analytical grade chemicals uric acid (C5H4N4O3, Sig-
ma), potassium hydroxide (KOH, Merck), hydrochloric
acid (HCl, Merck), magnesium chloride (MgCl2, Merck),
Tris – hydroxymethyl aminomethan (C4H11NO3, Merck),
magnesium sulphate heptahydrate (MgSO4.7H2O, Ke-
mika) and bidestiled water were used. Uric acid stock so-
lution was prepared by dissolving required amount of
chemical dried overnight in a desiccator over silica gel.
Concentration of KOH solution was determined by titra-
tion with HCl and concentration of magnesium chloride
by conductometric titration with silver nitrate. pH of the
solutions were adjusted to desired value by addition of
NaOH and/or HCl.
Preparation of magnesium urate octahydrate
Magnesium urate octahydrate was prepared by dis-
solving 400 mg of uric acid in 500 mL (2´10–2 moldm–3) of
Tris buffer (pH=8) with magnetic stirring. After dissolu-
tion solution was filtered through Millipore filter 0.22
mm, 3.5 g of MgSO4.7H2O was added to filtered solution
and pH was adjusted with KOH to 8. Solution was left
undisturbed at room temperature until crystals were
formed. After 3 hours needle-like crystals of phase I were
detected. After longer aging time, mixture of needle-like
and plate-like crystals was observed, and after 3 month
plate-like crystals of phase II were only crystals ob-
served. Crystals were filtered through Millipore filter
and dried before solubility experiments and character-
ization.
Solubility experiments
Solubility of Mg(HU)2.8H2O was determined in bi-
destiled water, uric acid(1.10–4 moldm–3) and magnesium
chloride solutions (1´10–3 moldm–3). Known amount of
Mg(HU)2·8H2O (about 200 mg) was weighted into Erlen-
meyer flask and 100 mL of solvent was added. Suspen-
sions were equilibrated in water bath at 310 K with con-
stant shaking. At predetermined time intervals aliquots
of suspension were taken and filtered through Millipore
filter 0.22 mm. In thus obtained filtrates concentrations
of uric acid and magnesium were determined. Precipi-
tates were filtered, dried and analyzed.
Please note that kinetics of dissolution were followed
in order to determine time needed for reaching equilib-
rium and to calculate solubility product. They were not
used in order to determine rate of dissolution constant.
Characterization of the solutions
pH of the solutions was measured by pH meter Mo. 26
(Radiometer, Copenhagen). Total concentration of uric
acid was determined by measuring absorption at 285
nm21 using UV spectrometers Beckman Model 34 and
Model Varian Cary 3. Total magnesium concentration
was determined by atomic absorption spectroscopy using
Perkin Elmer 3030B Atomic – Absorption Spectropho-
tometer.
Characterization of the precipitates
Mg(HU)2.8H2O crystals were characterized by:
i) optical microscopy – samples of the suspensions
were taken at predetermined time intervals, observed
and photographed by light and polarized microscopy us-
ing Orthoplan photomicroscop (Ernst Leitz, Wetzlar),
ii) thermogravimetric analysis (TG) – water and purin
content in dry precipitates was determined by thermal
analysis system Mettler TG 50. Rate of heating was 20
°C/min,
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iii) powder X-ray diffraction patterns (RTG) – powder
X-ray diffraction patterns were obtained by »Philips« PW
diffractometer with graphite filtered CuKa radiation,
iv) elemental analysis – carbon, hydrogen and nitro-
gen content was determined using microchemical analyt-
ical method.
Solubility product calculations
Concentration solubility product, Ksp can be deter-
mined from equilibrium solubility data:
Mg(HU)2.8H2O(s)Mg2+(aq)+2HU–(aq)+8H2O(l) (1)
Ksp= [Mg2+][HU–]2 (2)
If composition of solution in equilibrium with solid
phase is known, it is possible to calculate standard solu-
bility product:
Ksq=[ Mg2+][ HU–]2(Sy±)3/(cq)3 (3)
where y± is average activity coefficient, c is concentration.
In cases of sparingly soluble salts, when ionic strength is
not too high, average activity coefficient can be estimated
using Debye-Hückel limiting law:
logy±=–Acz+z–(Ic /cq)1/2 (4)
where z is charge number, Ac constant with values 0.5002,
0.5115, 0.5242 and 0.5296 at 288 K, 298 K, 310 K and 318
K respectively22,23.
Ionic strength, I, is given by:
Ic=(1/2)Sci zi2 (5)
where i represents ionic species.
Uric acid is weak acid which dissociate in two steps.
Hydrogenurate ions equilibrium concentration is deter-
mined by pH and total urate concentration. Therefore
uric acid dissociation constant should be taken into cal-
culations. Values of uric acid24–26 and water dissociation
constants22,27 at different temperatures are given in
Table 1.
For calculation of the solubility product computer
program »Magurat« was used28.
Results
Characterization of the precipitates
Formation and transformation of Mg(HU)2.8H2O dur-
ing synthesis was followed with optical microscopy (Fig-
ure 1). Small needle-like crystals appeared after 1 hour
(Figure 1a). After 3 hours aging time a mixture of nee-
dle-like (phase I) and plate-like crystals (phase II) was
observed (Figure 1b). Transformation of phase I into
phase II was completed after 3 month (Figure 1c).
Elemental analysis of the Mg(HU)2.8H2O crystals is
given in Table 2.
RTG powder patterns of phase I, mixture of the pha-
ses and of phase II contain reflections with d-lines values
in good agreement with existing data12,15. TG curves of
both phases point to their structural differences. Release
of water is a two step process. First to be released are two
molecules of crystal water followed by six water mole-
cules from magnesium hexahydrate cation, as deter-
mined from mass loss given in Table 3. Thermal decom-
position of phase I starts at higher temperature (97 °C),
than decomposition of phase II (70 °C). Second mass loss
occurs at 140 °C for phase I and at 155 °C for phase II.
Mass loss at around 300 °C corresponds to decomposition
of purin.
Phase I and phase II dissolution kinetics
at 310 K
Dissolution kinetics of both phases is shown at Figure
2. Dissolution of phase I reaches equilibrium earlier than
the one of phase II, as seen from the plateau in absor-
bance curves. Dissolution of phase I reaches equilibrium
after 30 min, while for phase II equilibrium is reached af-
ter 90 min. Similar results were obtained by measuring
Mg2+ concentration. Average Ksp values given in Table 4
were obtained as average values of Ksp determined in dif-
ferent time intervals after equilibrium was reached, i.e.
in time interval 60–180 min for phase I and 120–300 min
for phase II.
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TABLE 1
URIC ACID AND WATER DISSOCIATION CONSTANTS AT DIFFERENT TEMPERATURES
pK
Ref.
15 °C 25 °C 37 °C 45 °C
H2UH++HU– 5.65 5.61 5.44 5.34 24, 25
HU–H++ U2– 9.15 9.15 10.51 10.51 26
H2OH++OH– 14.35 13.99 13.61 13.39 22, 27
TABLE 2
ELEMENTAL ANALYSIS OF THE Mg(HU)2·8H2O
%Mg %C %H %N %H2O
Calculated 4.84 23.90 4.41 22.29 28.70
Obtained 5.58 24.10 4.16 22.12 29.50
Temperature influence on solubility of
Mg(HU)2·8H2O phase II at equilibrium
Crystals of Mg(HU)2·8H2O phase II were dissolved in
water at pH=7.09±0.08 and temperatures 15 °C, 25 °C,
37 °C and 45 °C (Figure 3). As can be seen from Figure 3
solubility increases with temperature, with abrupt in-
crease above 37 °C32.
pH influence on solubility of Mg(HU)2·8H2O phase
II in water at equilibrium and different
temperatures
Since uric acid is a dibasic acid, distribution of ionic
species, namely H2U, HU– and U2–, depends on the solu-
tion pH. In this part of the study a pH range 6.5–9.0 in
which HU– is dominant ionic species was chosen. Solubil-
ity of Mg(HU)2·8H2O depends on initial pH, this effect
being smallest at 15 °C and 25 °C. At 25 °C and 37 °C solu-
bility is higher at higher pH, and reversely at 45 °C (Fig-
ure 4)32.
Influence of common ion on solubility of
Mg(HU)2·8H2O phase II at equilibrium
In order to determine the influence of common ion on
solubility of Mg(HU)2·8H2O at equilibria crystals were
dissolved in uric acid (1´10–4 mol dm–3) and magnesium
chloride solutions (1´10–3 mol dm–3) at different tem-
peratures and pH=8. In all cases solubility increases
with temperature (Figure 5). At 15 °C and 25 °C lowest
Mg(HU)2·8H2O solubility has been in MgCl2 solutions,
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Fig. 1. Micrographs of the magnesium hydrogenurate octahydra-
te; a) needle-like crystals of phase I; b) mixture of the needle-like
crystals of phase I and plate-like crystals of phase II, c) plate-like
crystals of phase II. Magnification 400×.
TABLE 3
MASS LOSS OF Mg(HU)2·8H2O PHASE I AND PHASE II CRYSTALS
UPON HEATING TO 800 °C. RATE OF HEATING 20 °C/ MIN






Phase I 6.68 23.15 65.47
Phase II 7.56 21.06 66.16
Calculated 7.17 21.51 66.53
Fig. 2. Change of uric acid absorbance with aging time for the
phase I and phase II in water solutions at 37 °C.
while solubilities in water and H2U solutions don’t differ
much (Figures 5a and b). The difference in solubility is
decreasing with temperature (Figures 5c and d)32.
Solubility of phase II at 37 °C in different
solvents, t=24 hours
Solubilities of Mg(HU)2·8H2O thermodynamically
more stable phase II determined after 24 hours in water,
magnesium chloride and uric acid solutions are given in
Table 5. Solubility of Mg(HU)2·8H2O in magnesium chlo-
ride is higher than in water and uric acid. Measured pH
values indicate that in all suspensions uric acid crystals
can coexist with Mg(HU)2·8H2O crystals. This is confir-
med by H2U/Mg molar ratio 1:1 and RTG powder pattern
which contain characteristic peaks of both Mg(HU)2·
8H2O and uric acid20.
Discussion and Conclusions
Magnesium hydrogenurate octahydrate precipitates
in the form of two phases, thermodynamically less stable
phase I and more stable phase II12,15,20. The transforma-
tion of phase I to phase II is long process lasting up to 3
month20. As expected the solubility of phase I is higher
than that of phase II (Figure 2). Literature Ksp values of
anhydrous uric acid, uric acid dihydrate and calcium
hydrogenurate hexahydrate, as well as Ksp values of mag-
nesium hydrogenurate octahydrate phase I and II deter-
mined and described in this paper at 37 °C are listed in
Table 4. It can be seen that at equilibrium the most solu-
ble is Mg(HU)2·8H2O phase I, while calcium hydrogen-
urate hexahydrate is the least soluble compound. The
higer solubility of Mg(HU)2·8H2O phase I than uric acid
dihydrate can be the reason that Mg(HU)2·8H2O crystals
were not detected as urinary stone constituents in con-
trast to H2U·2H2O crystals which are frequent consti-
tuents11. Values obtained after longer aging time (24h)
can’t be used as reliable due to the partial transforma-
tion of calcium hydrogenurate hexahydrate and magne-
sium hydrogenurate octahydrate into uric acid.
Solubility of Mg(HU)2·8H2O phase II increases with
temperature (Figure 3). Ksp values determined at different
temperatures (Ksp(15 °C)=(2.18±0.46)·10–10 mol3 dm–9;
Ksp(25 °C)=(7.36±0.43)·10–10 mol3 dm–9; Ksp(37 °C)=
(6.15±0.30)·10–10 mol3 dm–9 and Ksp(45 °C)=(6.71± 1.28)·
10–9 mol3 dm–9)32 were used to calculate dissolution en-
thalpy and log Ksp vs. 1/T plots. As it can be seen from
Figure 6 the plot has discontinuity at 25 °C. This could be
explained by the existence of two kinds of water mole-
cules in the crystal structure, i.e. crystal and coordina-
tion water. Due to this difference it is probable that sev-
eral different reactions take place at the same time
during dissolution of Mg(HU)2· 8H2O. Phase II enthalpy
of dissolution determined from linear dependence of log
Ksp vs. 1/T at 15 °C, 37 °C and 45 °C is ÄsolH=86 kJmol–1.
According to the Le Chatelier principle, addition of
common ion shifts dissolution equilibrium towards solid
phase formation. That means that solubility of the salt is
lower in the presence of common ion. In the case of
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TABLE 4
SOLUBILITY PRODUCT, KSP, OF URIC ACID AND ITS CALCIUM AND MAGNESIUM SALTS AT 37 °C
Compound Medium Ksp´109 (equilibrium) Ksp´1010 (24 hours) Reference
H2U·2H2O water (2.25±0.05), 1 hour (0.18±0.003) 25, 29
H2U water 0.824 — 30
H2U water 0.987 — 24
Ca(HU)2·6H2O water (0.53±0.004), 3 hours 29, 31
Mg(HU)2·8H2O, phase I water (5.64±0.020), 1–3 hours — 20, this paper
Mg(HU)2·8H2O, phase II water (1.66±0.13), 2–5 hours (6.37±2.71) 20, this paper
Fig. 3. Dissolution kinetics of Mg(HU)2·8H2O in water at different
temperatures.  T=15 °C;  T=25 °C; T=37 °C; T=45 °C.
pH=7.09±0.08.
TABLE 5
SOLUBILITY OF Mg(HU)2·8H2O PHASE II IN WATER,
MAGNESIUM CHLORIDE AND URIC ACID SOLUTIONS AND
CORRESPONDING pH RANGE DURING AGING TIME AT 37 °C
AFTER 24 HOURS
Solvent Solubility, Ksp/mol3 dm–9 pH range
Water (6.366±2.709)´10–10 6.74–7.10
Magnesium chloride (5.038±1.726)´10–10 6.28–7.21
Uric acid (6.638±2.123)´10–10 6.61–6.88
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Fig. 4. Dissolution kinetics of Mg(HU)2·8H2O at a) 15 °C, b) 25 °C, c) 37 °C, d) 45 °C and at different pH.
Lines are only guidance for the eye.
Fig. 5. Dissolution kinetics of Mg(HU)2·8H2O at a) 15 °C, b) 25 °C, c) 37 °C, d) 45 °C and pH=8 in different solvents.
Lines are only guidance for the eye.
Mg(HU)2·8H2O phase II at equilibrium the solubility is
the lowest in the presence of excess of magnesium ions,
while solubility in the presence of uric acid, although
somewhat higher, is comparable with the one in water.
This trend is observed at all other investigated tempera-
tures. The difference in solubility in different solvents is
decreasing with increasing temperature (Figure 5). It is
assumed that Mg(HU)2·8H2O solubility is decreased by
magnesium chloride addition due to the formation of sol-
uble complexes which are in equilibrium with solid pha-
se.32 Phase II Ksp values after 24 hours in water, magne-
sium chloride and uric acid solutions at 37 °C (Table 5)
are lower than the value obtained in water in equilib-
rium conditions (Table 4). After 24 hours the solubility is
the highest in magnesium chloride solutions, contrary to
the equilibrium solubility and the Le Chatelier principle.
Also, standard deviation of measurements is higher in
these cases20. The reason again could be partial transfor-
mation of Mg(HU)2·8H2O into uric acid.
These results indicate that in order to fully under-
stand what is happening in urate solutions more work
needs to be done in determining the course and the ex-
tent of urates transformation to uric acid.
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Fig. 6. log Ksp of Mg(HU)2·8H2O phase II vs. 1/T plot, water,
pH≅7.0.
UTJECAJ PH, TEMPERATURE I ZAJEDNI^KOG IONA NA TOPLJIVOST
MAGNEZIJEVOG HIDROGENURATA OKTAHIDRATA
S A @ E T A K
Fizi~ko-kemijska istra`ivanja urolitijaze, danas su uglavnom usmjerena na primjenu fizi~ko-kemijskog opisa pro-
cesa talo`enja na stvaranje mokra}nih kamenaca s ciljem odre|ivanja potencijalnih stvaralaca kamenaca. Taj pristup
uklju~uje izra~un prezasi}enosti za razli~ite ~vrste faze koje mogu nastati u mokra}i. Pri tome se koriste rezultati
analize mokra}e i postoje}e konstante produkta topljivosti, disocijacije i kompleksiranja. Da bi izra~un bio valjan potre-
bno je uzeti u obzir sve vrste koje mogu nastati u sistemu. Magnezijev hidrogenurat oktahidrat, Mg(C5H3N4O3)2·8H2O
(Mg(HU)2·8H2O), je jedna od vrsta koja mo`e istalo`iti u mokra}i, a za koju ne postoje podaci o topljivosti. Pripremljeni
su i karakterizirani kristali Mg(C5H3N4O3)2·8H2O faze I i faze II. Konstante produkta topljivosti faze I u vodi na 37 °C,
te faze II pri razli~itim temperaturama, pH i otapalima odre|ene su mjerenjem ukupnih koncentracija mokra}ne kise-
line i magnezijevih iona u suspenzijama u razli~itim vremenskim intervalima. Rezultati pokazuju da je u vodi na 37 °C
termodinami~ki nestabilnija faza I (Ksp=(5,64±0,20)´10–9mol3dm–9) topljivija od termodinami~ki stabilnije faze II (Ksp=
(1,66±0,13)´10–9 mol3 dm–9). Topljivost (Mg(HU)2·8H2O faze II se pove}ava s temperaturom. U ravnote`nim uvjetima
topljivost faze II je najmanja u suvi{ku magnezijevih iona, dok je topljivost u suvi{ku uratnih iona sli~na topljivosti u
vodi.
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